In most cases, primary lung abscesses are successfully treated by empiric antibiotic therapy, followed by targeted therapy depending on gram stain and culture results with a cure rate of around 90%. Secondary abscesses need treatment of underlying causes to improve the outcome. Prognosis is poor, especially in immunocompromised patients and patients with bronchial neoplasm compared to primary lung abscess with a mortality rate of around 75%.